Recent advances in contraception

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Aiken, Abigail R A ^a   Trussell, James ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MIFEPRISTONE; MISOPROSTOL; ULIPRISTAL;

BODY WEIGHT; CONTRACEPTION; COUNSELING; DEVICE SAFETY; DRUG EFFICACY; EMERGENCY CONTRACEPTION; FOOD AND DRUG ADMINISTRATION; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL ABORTION; POLICY; PROGESTIN IMPLANT; PUERPERIUM; REIMBURSEMENT; REVIEW; SECOND TRIMESTER ABORTION; SEXUAL INTERCOURSE; UNPLANNED PREGNANCY; UTERUS PERFORATION;

EID: 84914819924     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-113     Document Type: Review

References (38)

1. Trussell J, Guthrie KA: Choosing a contraceptive: efficacy, safety, and personal considerations. In Contracetive Technology: Twentieth Revised Edition. Edited by Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar M. New York: Ardent Media; 2011: 45-74.
2. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF: The Contraceptive CHOICE Project: reducing barriers to longacting reversible contraception. Am J Obstet Gynecol 2010, 203:115.e1-7.
3. Sivin I, Alvarez F, Diaz J, Diaz S, el Mahgoub S, Coutinho E, Brache V, Diaz MM, Faundes A, Pavez M: Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Contraception 1984, 30:443-56.
4. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT: Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010, 116:625-32.
5. Mawet M, Nollevaux F, Nizet D, Wijzen F, Gordenne V, Tasev N, Segedi D, Marinescu B, Enache A, Parhomenko V, Frankenne F, Foidart J: Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a oneyear randomised controlled trial. Eur J Contracept Reprod Health Care 2014, 19:169-79.
6. Nelson A, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, Gemzell-Danielsson K: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 2013, 122:1205-13.
7. Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C: Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril 2014, 101:1656-62.e1-4.
8. Gemzell-Danielsson K, Schellschmidt I, Apter D: Arandomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012, 97:616-22.e1-3.
9. Baram I, Weinstein A, Trussell J: The IUB, a newly invented IUD: a brief report. Contraception 2014, 89:139-41.
10. Rowlands S, Sujan M, Cooke M: A risk management approach to the design of contraceptive implants. J Fam Plann Reprod Health Care 2010, 36:191-5.
11. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H, Gemzell-Danielsson K: Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010, 82:243-9.
12. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J: The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012, 27:1994-2000.
13. Cheng L, Che Y, Gülmezoglu AM: Interventions for emergency contraception. Cochrane Database Syst Rev 2012, 8:CD001324.
14. Hamoda H, Ashok PW, Stalder C, Flett, GMM, Kennedy E, Templeton A: A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet Gynecol 2004, 104:1307-13.
15. Hertzen H von, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Lüdicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Khomassuridze A, Apter D, Peregoudov A: Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002, 360:1803-10.
16. Fine P, Mathé H, Ginde S, Cullins V, Morfesis J, Gainer E: Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010, 115:257-63.
17. Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, Rosenberg M, Higgins J: Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006, 108:1089-97.
18. Glasier AF, Cameron ST, Fine PM, Logan, Susan JS, Casale W, van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E: Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010, 375:555-62.
19. Croxatto HB, Brache V, Pavez M, Cochon L, Forcelledo ML, Alvarez F, Massai R, Faundes A, Salvatierra AM: Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception 2004, 70:442-50.
20. Brache V, Cochon L, Jesam C, Maldonado R, Salvatierra AM, Levy DP, Gainer E, Croxatto HB: Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod 2010, 25:2256-63.
21. Summary of Product Characteristics for Norlevo 1.5mg tablet. [http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/]
22. Hertzen H von, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Lüdicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Khomassuridze A, Apter D, Peregoudov A: Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002, 360:1803-10.
23. Task Force on Postovulatory Methods of Fertility Regulation: Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1998, 352:428-33.
24. Dada OA, Godfrey EM, Piaggio G, Hertzen H Von: A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception 2010, 82:373-8.
25. Press Release: European Medicines Agency: Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight. [http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2014/07/news-detail-002145.jsp&mid=WC0b01ac058004d5c1]
26. Reeves MF, Smith KJ, Creinin MD: Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis. Obstet Gynecol 2007, 109:1286-94.
27. Langston AM, Joslin-Roher SL, Westhoff CL: Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice. Contraception 2014, 89:103-8.
28. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A: Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008, 78:143-8.
29. Roberts H, Silva M, Xu S: Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand. Contraception 2010, 82:260-5.
30. Cameron ST, Glasier A, Chen ZE, Johnstone A, Dunlop C, Heller R: Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. BJOG 2012, 119:1074-80.
31. U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep 2010, 59:1-86.
32. Sääv I, Stephansson O, Gemzell-Danielsson K: Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trial. PLoS ONE 2012, 7:e48948.
33. Thompson, Kirsten MJ, Speidel JJ, Saporta V, Waxman NJ, Harper CC: Contraceptive policies affect post-abortion provision of long-acting reversible contraception. Contraception 2011, 83:41-7.
34. Grossman D, Ellertson C, Grimes DA, Walker D: Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004, 103:738-45.
35. Tsao T, Yunzal-Butler C, Sackoff J, Kaplan D: Medicaid reimbursement for immediate post-abortion provision of long-acting reversible contraception reduces both unintended pregnancies and health care expenditures. Contraception 2014, [Epub ahead of print].
36. Teal SB: Postpartum contraception: optimizing interpregnancy intervals. Contraception 2014, 89:487-8.
37. Kapp N, Curtis KM: Intrauterine device insertion during the postpartum period: a systematic review. Contraception 2009, 80:327-36.
38. Grimes DA, Lopez LM, Schulz KF, Van Vliet, Huib Aam, Stanwood NL: Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2010: CD003036.